Form 4 for EW Edwards Lifesciences
Accepted 2026-05-29 16:44:17 ET · period of report 2026-05-29 · accession 0001225208-26-005647 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 16:44 | 2026-05-29 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | S - Sale | $86.08 | -567.53 | 15.3K | -4% | -$48.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-29 | S | D | 567.53 | $86.08 | 15,334.09 | D | — | — |